A 42-year-old woman with stage IB2 cervical squamous cell carcinoma (SCC) is deemed suitable for concurrent chemoradiation therapy. Which agent is the drug of choice for radiosensitization during pelvic radiotherapy?
See the options, answer & explanation
Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.